| Identification | |
| Name: | Maraviroc |
| Synonyms: | Cyclohexanecarboxamide,4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-;Celsentri;UK 427857; |
| CAS: | 376348-65-1 |
| Molecular Formula: | C29H41F2N5O |
| Molecular Weight: | 513.67 |
| InChI: | InChI=1/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.29 g/cm3 |
| Refractive index: | 1.627 |
| Appearance: | Brown Solid |
| Specification: |
?Maraviroc , its cas register number is 376348-65-1. It also can be called 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide ; and Selzentry . |
| Usage: | Maraviroc (CAS NO.376348-65-1) has been used for non-competitive CCR5 receptor antagonist as a potent antiviral durg inhibiting binding of HIV viral coat protein gp120. |
| Safety Data | |
 |
|
